These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 24203724

  • 1. Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings.
    Gillespie KM, Aitken RJ, Wilson I, Williams AJ, Bingley PJ.
    Diabetes; 2014 Mar; 63(3):1041-7. PubMed ID: 24203724
    [Abstract] [Full Text] [Related]

  • 2. No extreme genetic risk for type 1 diabetes among DR3/4-DQ8 siblings sharing both extended HLA haplotypes with their diabetic proband.
    Eerligh P, Koeleman BP, Lie BA, Roep BO, Thorsby E.
    Tissue Antigens; 2011 Apr; 77(4):338-40. PubMed ID: 21388358
    [Abstract] [Full Text] [Related]

  • 3. Extreme genetic risk for type 1A diabetes.
    Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS.
    Proc Natl Acad Sci U S A; 2006 Sep 19; 103(38):14074-9. PubMed ID: 16966600
    [Abstract] [Full Text] [Related]

  • 4. Homozygosity for premature stop codon of the MHC class I chain-related gene A (MIC-A) is associated with early activation of islet autoimmunity of DR3/4-DQ2/8 high risk DAISY relatives.
    Ide A, Babu SR, Robles DT, Wang T, Erlich HA, Bugawan TL, Rewers M, Fain PR, Eisenbarth GS.
    J Clin Immunol; 2005 Jul 19; 25(4):303-8. PubMed ID: 16133985
    [Abstract] [Full Text] [Related]

  • 5. Self-reported lower respiratory tract infections and development of islet autoimmunity in children with the type 1 diabetes high-risk HLA genotype: the MIDIA study.
    Rasmussen T, Witsø E, Tapia G, Stene LC, Rønningen KS.
    Diabetes Metab Res Rev; 2011 Nov 19; 27(8):834-7. PubMed ID: 22069269
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ in diabetes mellitus-a study in 609 Swedish subjects.
    Törn C, Hillman M, Sanjeevi CB, Landin-Olsson M.
    Hum Immunol; 2006 Jul 19; 67(7):527-34. PubMed ID: 16829307
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
    El-Amir MI, El-Feky MA, Laine AP, Härkönen T, El-Badawy O, Eltayeb AA, El-Melegy TT, Kiviniemi M, Knip M, Ilonen J.
    Diabetes Metab Res Rev; 2015 Mar 19; 31(3):287-94. PubMed ID: 25256132
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease.
    Smigoc Schweiger D, Mendez A, Kunilo Jamnik S, Bratanic N, Bratina N, Battelino T, Brecelj J, Vidan-Jeras B.
    Autoimmunity; 2016 Jun 19; 49(4):240-7. PubMed ID: 27138053
    [Abstract] [Full Text] [Related]

  • 17. Risk of pediatric celiac disease according to HLA haplotype and country.
    Liu E, Lee HS, Aronsson CA, Hagopian WA, Koletzko S, Rewers MJ, Eisenbarth GS, Bingley PJ, Bonifacio E, Simell V, Agardh D, TEDDY Study Group.
    N Engl J Med; 2014 Jul 03; 371(1):42-9. PubMed ID: 24988556
    [Abstract] [Full Text] [Related]

  • 18. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.
    J Autoimmun; 1998 Dec 03; 11(6):643-50. PubMed ID: 9878086
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes.
    Hannelius U, Beam CA, Ludvigsson J.
    Diabetologia; 2020 Oct 03; 63(10):2177-2181. PubMed ID: 32754804
    [Abstract] [Full Text] [Related]

  • 20. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
    Spinas GA, Keller U, Neri TM, Matter L, Staffelbach O, Berger W.
    Schweiz Med Wochenschr; 1985 Jan 12; 115(2):48-54. PubMed ID: 3881821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.